Skip to main content
Log in

Mesoporous Carbon Nanoparticles as Multi-functional Carriers for Cancer Therapy Compared with Mesoporous Silica Nanoparticles

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Mesoporous carriers have been widely used to deliver anticancer drugs due to their unique characteristics. In this work, mesoporous silica nanoparticles (MSN) and mesoporous carbon nanoparticles (MCN) with substantially similar and uniform particle size, specific surface area, and pore size were prepared to compare the photothermal effect, drug loading efficiencies (LE), and drug release properties. In order to improve the dispersion stability and biocompatibility of the carriers, MSN and MCN were grafted with PEG, respectively. The NIR-induced photothermal effect results indicated that MCN had a brilliant photothermal conversion efficiency due to its strong near-infrared absorption capacity, while MSN had no photothermal conversion capability. Moreover, LE of DOX in DOX/MCN-PEG reached 36.58%, higher than that in DOX/MSN-PEG, which was ascribed to non-covalent interaction of π-π stacking and electrostatic attraction. In addition, compared to DOX/MSN-PEG, DOX/MCN-PEG had a significantly increased release rate under NIR laser irradiation due to excellent photothermal conversion capability of MCN-PEG. Furthermore, cell viability assay and cellular uptake experiment results demonstrated that DOX/MCN-PEG showed a synergistic therapeutic effect in the combination of chemotherapy and phototherapy, with a combination index (CI) of 0.238.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Khatri N, Baradia D, Vhora I, Rathi M, Misra A. cRGD grafted liposomes containing inorganic nano-precipitate complexed siRNA for intracellular delivery in cancer cells. J Control Release. 2014;182(10):45–57.

    CAS  PubMed  Google Scholar 

  2. Strong LE. Hydrogel-nanoparticle composites for optically modulated cancer therapeutic delivery. J Control Release. 2014;178(1):63–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Zhenjiang Z, Jing W, Xin N, Tao W, Yinglu J, Xiaochun W, et al. Near infrared laser-induced targeted cancer therapy using thermoresponsive polymer encapsulated gold nanorods. J Am Chem Soc. 2014;136(20):7317–26.

    Google Scholar 

  4. Zongxi L, Barnes JC, Aleksandr B, J Fraser S, Zink JI. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev. 2012;41(7):2590–605.

    Google Scholar 

  5. Gu J, Su S, Li Y, He Q, Shi J. Hydrophilic mesoporous carbon nanoparticles as carriers for sustained release of hydrophobic anti-cancer drugs. Chem Commun (Camb). 2011;47(7):2101–3.

    CAS  Google Scholar 

  6. Fang Y, Gu D, Zou Y, Wu Z, Li F, Che R, et al. A low-concentration hydrothermal synthesis of biocompatible ordered mesoporous carbon nanospheres with tunable and uniform size. Angew Chem Int Ed Eng. 2010;49(43):7987–91.

    CAS  Google Scholar 

  7. Zhu J, Liao L, Bian X, Kong J, Yang P, Liu B. pH-controlled delivery of doxorubicin to cancer cells, based on small mesoporous carbon nanospheres. Small. 2012;8(17):2715–20.

    CAS  PubMed  Google Scholar 

  8. Kim TW, Chung PW, Slowing II, Tsunoda M, Yeung ES, Lin VS. Structurally ordered mesoporous carbon nanoparticles as transmembrane delivery vehicle in human cancer cells. Nano Lett. 2008;8(11):3724–7.

    CAS  PubMed  Google Scholar 

  9. Ma TY, Liu L, Yuan ZY. Direct synthesis of ordered mesoporous carbons. Chem Soc Rev. 2013;42(9):3977–4003.

    CAS  PubMed  Google Scholar 

  10. Yannan Z, Vivero-Escoto JL, Slowing II, Trewyn BG, Victor S-YL. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery. Expert Opin Drug Deliv. 2010;7(9):1013.

    Google Scholar 

  11. Wang H, Sun Y, Yi J, Fu J, Di J, Alonso ADC, et al. Fluorescent porous carbon nanocapsules for two-photon imaging, NIR/pH dual-responsive drug carrier, and photothermal therapy. Biomaterials. 2015;53(5):117–26.

    PubMed  Google Scholar 

  12. Zhao Q, Wang T, Jing W, Li Z, Jiang T, Gang C, et al. Fabrication of mesoporous hydroxycarbonate apatite for oral delivery of poorly water-soluble drug carvedilol. J Non-Crystal Solids. 2012;358(2):229–35.

    CAS  Google Scholar 

  13. Huang-Chiao H, Sutapa B, Gaurav S, Dey SK, Kaushal R. Inorganic nanoparticles for cancer imaging and therapy. J Control Release. 2011;155(3):344–57.

    Google Scholar 

  14. Fangqiong T, Linlin L, Dong C. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater. 2012;24(12):1504–34.

    Google Scholar 

  15. Jie L, Monty L, Zink JI, Fuyuhiko T. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small. 2010;3(8):1341–6.

    Google Scholar 

  16. Hui W, Shi L, Yan T, Zhang J, Zhong Q, Zhang D. Design of graphene-coated hollow mesoporous carbon spheres as high performance electrodes for capacitive deionization. J Mater Chem A. 2014;2(13):4739.

    Google Scholar 

  17. Guo L, Cui X, Li Y, He Q, Zhang L, Bu W, et al. Hollow mesoporous carbon spheres with magnetic cores and their performance as separable bilirubin adsorbents. Chem-Asian J. 2010;4(9):1480–5.

    Google Scholar 

  18. Jain RK. Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J Clin Oncol. 2013;31(17):2205–U210.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, Sharmila A, et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature. 2009;458(7239):732–6.

    CAS  PubMed  Google Scholar 

  20. Li W, Yan Y, Min W, Hong Y, Yang S. An integrated nanoplatform for theranostics via multifunctional core/shell ferrite nanocubes. J Mater Chem B. 2016;4(10):1908–14.

    Google Scholar 

  21. Xiao Q, Zheng X, Bu W, Ge W, Zhang S, Chen F, et al. editors. A core/satellite multifunctional nanotheranostic forin vivo imaging and tumor eradication by radiation/photothermal synergistic therapy. J Am Chem Soc. 2013;135(35):13041–8.

  22. Wang H, Zhao Y-L, Nie G-J. Multifunctional nanoparticle systems for combined chemoand photothermal cancer therapy. Front Mater Sci. 2013;7(2):118–28.

    Google Scholar 

  23. Kai Y, Huan X, Liang C, Chunyang S, Jun W, Zhuang L. In vitro and in vivo near-infrared photothermal therapy of cancer using polypyrrole organic nanoparticles. Adv Mater. 2013;25(7):5586–92.

    Google Scholar 

  24. Ruichan L, Piaoping Y, Fei H, Shili G, Chunxia L, Yunlu D, et al. A yolk-like multifunctional platform for multimodal imaging and synergistic therapy triggered by a single near-infrared light. ACS Nano. 2015;9(2):1630–47.

    Google Scholar 

  25. Fei H, Yang G, Yang P, Yu Y, Lin J. A new single 808 nm NIR light-induced imaging-guided multifunctional cancer therapy platform. Adv Funct Mater. 2015;25(25):3966–76.

    Google Scholar 

  26. Song X, Qian C, Zhuang L. Recent advances in the development of organic photothermal nano-agents. Nano Res. 2015;8(2):340–54.

    CAS  Google Scholar 

  27. Liu B, Li C, Xie Z, Hou Z, Cheng Z, Jin D, et al. 808 nm photocontrolled UCL imaging guided chemo/photothermal synergistic therapy with single UCNPs-CuS@PAA nanocomposite. Dalton Trans. 2016;45(33):13061–9.

    CAS  PubMed  Google Scholar 

  28. Li Y, Jiang C, Zhang D, Wang Y, Ren X, Ai K, et al. Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor. Acta Biomater. 2017;47:124–34.

    CAS  PubMed  Google Scholar 

  29. Gao Z, Liu X, Deng G, Zhou F, Zhang L, Wang Q, et al. Fe3O4@mSiO2-FA-CuS-PEG nanocomposites for magnetic resonance imaging and targeted chemo-photothermal synergistic therapy of cancer cells. Dalton Trans. 2016;45(34):13456–65.

    CAS  PubMed  Google Scholar 

  30. Yanlan L, Kelong A, Jianhua L, Mo D, Yangyang H, Lehui L. Dopamine-melanin colloidal nanospheres: an efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy. Adv Mater. 2013;25(9):1353–9.

    Google Scholar 

  31. Chen W, Ouyang J, Liu H, Chen M, Zeng K, Sheng J, et al. Black phosphorus nanosheet-based drug delivery system for synergistic photodynamic/photothermal/chemotherapy of cancer. Adv Mater. 2017;29(5)1603864

  32. Peng MY, Zheng DW, Wang SB, Cheng SX, Zhang XZ. Multifunctional nanosystem for synergistic tumor therapy delivered by two-dimensional MoS2. ACS Appl Mater Interfaces. 2017;9(16):13965–75.

    CAS  PubMed  Google Scholar 

  33. Li X, Wang X, Sha L, Wang D, Shi W, Zhao Q, et al. Thermosensitive lipid bilayer-coated mesoporous carbon nanoparticles for synergistic thermochemotherapy of tumor. ACS Appl Mater Interfaces. 2018;10(23):19386–97.

    CAS  PubMed  Google Scholar 

  34. Zhang W, Guo Z, Huang D, Liu Z, Guo X, Zhong H. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials. 2011;32(33):8555–61.

    CAS  PubMed  Google Scholar 

  35. Qin X, Guo Z, Liu Z, Zhang W, Wan M, Yang B. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. J Photochem Photobiol B. 2013;120:156–62.

    CAS  PubMed  Google Scholar 

  36. Xu G, Liu S, Niu H, Lv W, Wu R. Functionalized mesoporous carbon nanoparticles for targeted chemo-photothermal therapy of cancer cells under near-infrared irradiation. RSC Adv. 2014;4(64):33986–97.

    CAS  Google Scholar 

  37. Wu, Chao G, Hu H, Jiawen. Stability of thiolated PEG 5000-coated gold colloids: from DLVO stability to steric stability. Acta Chim Sin. 2009;67:1621–5.

    CAS  Google Scholar 

  38. Wu C, Guo H, Hu J. Stability of thiolated PEG 5000-coated gold colloids: from DLVO stability to steric stability. Acta Chim Sin. 2009;67:1621–5.

    CAS  Google Scholar 

  39. Wang Y, Cui Y, Zhao Y, Zhao Q, He B, Zhang Q, et al. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation. J Colloid Interface Sci. 2018;513:736.

    CAS  PubMed  Google Scholar 

  40. Li X, Yan Y, Lin Y, Jiao J, Wang D, Di D, et al. Hollow mesoporous carbon as a near-infrared absorbing carrier compared with mesoporous carbon nanoparticles for chemo-photothermal therapy. J Colloid Interface Sci. 2017;494:159–69.

    CAS  PubMed  Google Scholar 

  41. He Q, Zhang J, Shi J, Zhu Z, Zhang L, Bu W, et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials. 2010;31(6):1085–92.

    CAS  PubMed  Google Scholar 

  42. Jinlou GU, Shasha SU, Zhu M, Yongsheng LI, Zhao W, Duan Y, et al. Targeted doxorubicin delivery to liver cancer cells by PEGylated mesoporous silica nanoparticles with a pH-dependent release profile. Microporous Mesoporous Mater. 2012;161(5):160–7.

    Google Scholar 

  43. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63.

    CAS  PubMed  Google Scholar 

  44. Slowing II, Chia-Wen W, Vivero-Escoto JL, Victor S-YL. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small. 2010;5(1):57–62.

    Google Scholar 

  45. Zhao Q, Liu J, Zhu W, Sun C, Di D, Zhang Y, et al. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Acta Biomater. 2015;23:147–56.

    PubMed  Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundation of China (No. 81603058 and 81401501) and Youth Project of Liaoning Provincial Education Department (No. 2017LQN20).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ying Zhang or Siling Wang.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 144 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, M., Zhao, Q., Wu, Y. et al. Mesoporous Carbon Nanoparticles as Multi-functional Carriers for Cancer Therapy Compared with Mesoporous Silica Nanoparticles. AAPS PharmSciTech 21, 42 (2020). https://doi.org/10.1208/s12249-019-1604-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/s12249-019-1604-8

KEY WORDS

Navigation